Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Tea, tap water and child IQ: What a Canadian pregnancy study found

31

Jul 2026

Tea, tap water and child IQ: What a Canadian pregnancy study found

Researchers analyzed 485 mother-child pairs in Canada to examine whether estimated fluoride intake from tea during pregnancy was associated with IQ at ages 3 to 4. Each 0.5 mg/day increase was associated with a 2.24-point lower full-scale IQ score, although the observational design and estimated exposure prevent causal conclusions.

Hydrogen-powered shipping could deliver $284 billion in annual health benefits

31

Jul 2026

Hydrogen-powered shipping could deliver $284 billion in annual health benefits

Researchers modeled how replacing conventional global shipping fuels with hydrogen could change PM2.5 and ozone pollution, premature mortality, and monetized health benefits. Under complete transition, the model estimated 129,458 fewer premature deaths and US$284 billion in annual monetized health benefits, although some regions experienced increased pollution from hydrogen production or altered ozone chemistry.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.